Earth Science Tech ETST

OTC ETST
$0.09 +0.00 (+0.00%)
At close: Nov 6, 2026 · 4:00 PM EST

Earth Science Tech (ETST) stock price is $0.09, unchanged on the day, as of Nov 6, 2026. It has a market cap of $28.76Mn and a P/E ratio of 7.46, and is classified in the Generic Drugs industry (Healthcare sector).

Key Stats
Market Cap28.76 Mn
P/E7.46
FCF (Yr)1.04 Mn
ROA (Yr)44.91
EV to EBIT0.00
Net Income (Yr)3.60 Mn
Enterprise Value20.04 Mn
Add ratio to table…

About

Earth Science Tech, Inc. operates as a strategic holding company focused on value creation through the acquisition, operational optimization, and management of its operating businesses. The company leverages a diversified portfolio of subsidiaries to create synergies across pharmacy, telemedicine, real estate, healthcare services, and consumer products. Earth Science Tech, Inc. generates revenue primarily from product sales of compounded medications through its RxCompound…

Read more ↓
Sector: Healthcare Sector rationale The company's primary revenue drivers are its compounding pharmacies (RxCompound and Mister Meds), telemedicine referral platform (Peaks Curative), and healthcare facility services (Las Villas Health Care). A secondary sector of Real Estate is justified because the company operates Avenvi, a substantial business line dedicated to real estate development, asset management, and financing. Industries: +2 more Generic Drugs Generic Drugs Primary The company generates primary revenue from the sale of compounded medications through its RxCompound and Mister Meds pharmacies, which are licensed compounding pharmacies. Telehealth Telehealth Secondary The company operates Peaks Curative, a telemedicine referral platform that offers asynchronous consultations for patients seeking compounded medications. Healthcare Services Healthcare Services Secondary The company operates Las Villas Health Care, a brick-and-mortar healthcare facility providing specialized sexual health treatments and physical performance solutions. Classified using BQ-MICS CIK: 0001538495

Product and Service Breakdown of Revenue (2026)

History
Peer percentiles

How Earth Science Tech ranks

Ranked against the 671 companies in Pharmaceuticals and Biotechnology58 metrics · as of Nov 6, 2026

Valuation

12 metrics · Lower multiples rank higher; a negative multiple ranks last
  • P/E 7.46xMedian 17.8x 97th
  • P/FCF 14.3xMedian 21.0x 95th
  • P/Operating cash flow 12.5xMedian 16.8x 94th
  • P/S 0.80xMedian 8.14x 92nd
  • P/B 3.91xMedian 2.02x 29th
  • P/Tangible book 4.02xMedian 2.24x 30th
  • EV/EBITDA 6.55xMedian 15.7x 97th
  • EV/EBIT 7.12xMedian 20.9x 96th
  • EV/Revenue 0.72xMedian 5.92x 91st
  • EV/FCF 12.9xMedian 22.0x 94th
  • EV/Operating cash flow 11.2xMedian 18.3x 94th
  • PEG (3Y EPS CAGR) 0.04Median 0.36 93rd
Peer group

Peer Comparison

Companies in the Generic Drugs
View all peers
S.No. Ticker Company Market CapP/EP/STotal Debt (Qtr)
1 LLY ELI LILLY & Co 1,261.99 Bn45.7614.6049.50 Bn
2 JNJ Johnson & Johnson 678.93 Bn42.186.8344.65 Bn
3 ABBV AbbVie Inc. 518.29 Bn50.127.8580.90 Bn
4 MRK Merck & Co., Inc. 365.98 Bn149.205.4353.78 Bn
5 NVS Novartis Ag 316.85 Bn17.915.08-
6 AZN Astrazeneca Plc 293.40 Bn26.604.94-11.96 Bn
7 AMGN Amgen Inc 251.78 Bn26.816.4754.01 Bn
8 ETST Earth Science Tech, Inc. 0.03 Bn7.460.80-